Low dose baclofen and standard dose acamprosate had comparable changes in brain glutamate, brain Gamma amino butyric acid (GABA) and craving among patients with alcohol dependence syndrome: A 1H-MRS based open label randomized study
Background: Understanding of the mechanism of action of Baclofen as anticraving inalcohol dependence syndrome (ADS) is limited. Aim: Our study aimed to examine and compareearly changes in brain glutamate and GABA with Baclofen and Acamprosate among patients with alcohol dependence syndrome. Material...
Saved in:
| Main Authors: | Akhil Kesan, Pranjal Dey, Sourav Khanra, Samiksha Singhai, Monalisa Boro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Industrial Psychiatry Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ipj.ipj_187_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparative study evaluating the efficacy of naltrexone versus acamprosate as anticraving agents in alcohol use disorder
by: Samant Singh, et al.
Published: (2025-01-01) -
Review of acamprosate pharmacokinetics and dosing strategies
by: Lauren Steil, PharmD, et al.
Published: (2025-04-01) -
Neuroprotective role of acamprosate and rasagiline in epilepsy: In silico and in vivo study
by: Kumar Sandeep, et al.
Published: (2025-01-01) -
ELECTROENCEPHALOGRAPHY SHOWING DYING BRAIN IN A PATIENT WITH ACUTE BACLOFEN POISONING
by: A. Y. Mikhaylov, et al.
Published: (2018-01-01) -
Lung Histopathology in Baclofen Intoxication
by: O. L. Romanova, et al.
Published: (2021-04-01)